Загрузка...
Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma
OBJECTIVE: To evaluate the performance of the nuclear matrix protein 22 (NMP22) BladderChek test in urothelial carcinoma (UC). METHODS: We retrospectively analyzed 1318 patients who performed the NMP22 BladderChek tests. Of them, 103 were primary UC patients, 90 were surgical treatment UC patients,...
Сохранить в:
| Опубликовано в: : | Dis Markers |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7232672/ https://ncbi.nlm.nih.gov/pubmed/32454904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3424039 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|